Publications

Ishii M, Wang G, Racchumi G, Dyke JP, Iadecola C.  2014.  Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons.. J Neurosci. 34(27):9096-106.

Ishii M.  2016.  The Role of the Adipocyte Hormone Leptin in Alzheimer's Disease.. Keio J Med. 65(1):21.

Ishii M, Kamel H, Iadecola C.  2018.  Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.. J Alzheimers Dis.

Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M.  2019.  Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease.. Alzheimers Dement (Amst). 11:646-653.

Ishii M, Iadecola C.  2015.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.. Cell Metab. 22(5):761-76.

McGuire MJ, Ishii M.  2016.  Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies.. Cell Mol Neurobiol. 36(2):203-17.

Hiller AJ, Ishii M.  2018.  Disorders of Body Weight, Sleep and Circadian Rhythm as Manifestations of Hypothalamic Dysfunction in Alzheimer's Disease.. Front Cell Neurosci. 12:471.

Ishii M.  2019.  Apolipoprotein B as a New Link Between Cholesterol and Alzheimer Disease.. JAMA Neurol.

Ishii M, Hiller AJ, Pham L, McGuire MJ, Iadecola C, Wang G.  2019.  Amyloid-beta modulates low-threshold activated voltage-gated L-type calcium channels of arcuate neuropeptide Y neurons leading to calcium dysregulation and hypothalamic dysfunction.. J Neurosci.

Ishii M, Iadecola C.  2016.  Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology.. Biochim Biophys Acta. 1862(5):966-74.